Status:
TERMINATED
PreOxygenation for EndoTracheal Intubations
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Intubation Complication
Preoxygenation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hypoxemia is a life threatening complication during emergency airway management. Despite advances in technology and training, hypoxemia still occurs in up to a quarter of all intubations placing patie...
Detailed Description
In emergency and critical care medicine, one of the most common incidences of severe hypoxemia occurs during the process of endotracheal intubations. Endotracheal intubations, also known as insertion ...
Eligibility Criteria
Inclusion
- Patients with a pre-existing arterial line
- Age \> 18
- Able to provide consent
Exclusion
- Acute respiratory distress Defined as RR \>30, Baseline oxygen requirements \>50%, current use of High Flow Nasal Cannulae or Non-invasive ventilation for respiratory support
- Decreased level of consciousness GCS \<13
- Possible exclusion if the allocation to prespecified groups are filled
- Contraindication for high oxygen therapy Severe Chronic Obstructive Pulmonary Disease with documented CO2 retention based on outpatient ABG History of Bleomycin use
- Significant hemodynamic instability Lactate \> 3 mmol/L Norepinephrine dose \>0.2 mcg/kg/min or equivalent dose of other vasopressors
Key Trial Info
Start Date :
July 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2023
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT03240614
Start Date
July 30 2018
End Date
March 15 2023
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada, B3H 3G1